ID   MCF-12F
AC   CVCL_3745
SY   MCF12F; Michigan Cancer Foundation-12F
DR   BTO; BTO:0002545
DR   CLO; CLO_0007604
DR   ATCC; CRL-3599
DR   ATCC; CRL-10783
DR   GEO; GSM756373
DR   Wikidata; Q54904303
RX   Patent=US5206165;
RX   PubMed=24162158;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10783.
CC   Population: Caucasian.
CC   Doubling time: ~20 hours (ATCC=CRL-3599).
CC   Discontinued: ATCC; CRL-10783; true.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008359.
ST   Source(s): ATCC=CRL-3599
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 9,12
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3744 ! MCF-12A
SX   Female
AG   63Y
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
RX   Patent=US5206165;
RA   Pauley R.J., Paine T.J., Soule H.D.;
RT   "Immortal human mammary epithelial cell sublines.";
RL   Patent number US5206165, 27-Apr-1993.
RX   PubMed=24162158; DOI=10.1007/s10549-013-2743-3;
RA   Prat A., Karginova O., Parker J.S., Fan C., He X.-P., Bixby L.M.,
RA   Harrell J.C., Roman E., Adamo B., Troester M.A., Perou C.M.;
RT   "Characterization of cell lines derived from breast cancers and normal
RT   mammary tissues for the study of the intrinsic molecular subtypes.";
RL   Breast Cancer Res. Treat. 142:237-255(2013).